FADS1 encodes delta-5 desaturase, an enzyme involved in converting polyunsaturated fatty acids (e.g., ALA to EPA). Variants like rs174537 are associated with altered omega-3 and omega-6 levels. Some studies link FADS1 to inflammation and insulin sensitivity, which could indirectly affect metabolism. However, there is no strong evidence that FADS1 variants directly cause or hinder weight loss. Weight loss is driven by energy balance, macronutrient composition, physical activity, and many other genetic factors. Consumer tests marketing FADS1 as a 'weight loss gene' overstate its clinical relevance. The effect size is small, and dietary changes (e.g., increasing omega-3 intake) can modulate the impact. Bottom line: FADS1 is an interesting marker for fatty acid metabolism but not a decision point for diet success. Clinical actions should be based on overall context.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-74e9dbccb19cf749071d874d